258 related articles for article (PubMed ID: 23418377)
21. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
[TBL] [Abstract][Full Text] [Related]
22. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
Nevskaya T; Baron M; Pope JE;
Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
[TBL] [Abstract][Full Text] [Related]
24. Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database.
Baron M; Hudson M; Steele R;
J Rheumatol; 2009 Dec; 36(12):2737-43. PubMed ID: 19833750
[TBL] [Abstract][Full Text] [Related]
25. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
[TBL] [Abstract][Full Text] [Related]
26. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.
Hoffmann-Vold AM; Molberg Ø; Midtvedt Ø; Garen T; Gran JT
J Rheumatol; 2013 Jul; 40(7):1127-33. PubMed ID: 23637316
[TBL] [Abstract][Full Text] [Related]
27. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.
Ghrénassia E; Avouac J; Khanna D; Derk CT; Distler O; Suliman YA; Airo P; Carreira PE; Foti R; Granel B; Berezne A; Cabane J; Ingegnoli F; Rosato E; Caramaschi P; Hesselstrand R; Walker UA; Alegre-Sancho JJ; Zarrouk V; Agard C; Riccieri V; Schiopu E; Gladue H; Steen VD; Allanore Y
J Rheumatol; 2014 Jan; 41(1):99-105. PubMed ID: 24293584
[TBL] [Abstract][Full Text] [Related]
28. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
Pope J; Harding S; Khimdas S; Bonner A; ; Baron M
J Rheumatol; 2012 Mar; 39(3):524-31. PubMed ID: 22247347
[TBL] [Abstract][Full Text] [Related]
29. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.
Vanthuyne M; Smith V; De Langhe E; Van Praet J; Arat S; Depresseux G; Westhovens R; Blockmans D; Badot V; Cogan E; De Keyser F; Houssiau FA
J Rheumatol; 2012 Nov; 39(11):2127-33. PubMed ID: 22984273
[TBL] [Abstract][Full Text] [Related]
30. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients.
Thombs BD; Hudson M; Bassel M; Taillefer SS; Baron M;
Arthritis Rheum; 2009 Jul; 61(7):966-73. PubMed ID: 19565539
[TBL] [Abstract][Full Text] [Related]
31. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
Hashimoto A; Tejima S; Tono T; Suzuki M; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
[TBL] [Abstract][Full Text] [Related]
32. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E
Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843
[TBL] [Abstract][Full Text] [Related]
33. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis.
Thompson AE; Pope JE
J Rheumatol; 2002 Sep; 29(9):1867-73. PubMed ID: 12233880
[TBL] [Abstract][Full Text] [Related]
34. Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline.
Massardo L; Pons-Estel BA; Wojdyla D; Cardiel MH; Galarza-Maldonado CM; Sacnun MP; Soriano ER; Laurindo IM; Acevedo-Vásquez EM; Caballero-Uribe CV; Padilla O; Guibert-Toledano ZM; da Mota LM; Montufar RA; Lino-Pérez L; Díaz-Coto JF; Achurra-Castillo AF; Hernández JA; Esteva-Spinetti MH; Ramírez LA; Pineda C; Furst DE
Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1135-43. PubMed ID: 22505270
[TBL] [Abstract][Full Text] [Related]
35. Malignancies associated with systemic sclerosis.
Szekanecz É; Szamosi S; Horváth Á; Németh Á; Juhász B; Szántó J; Szücs G; Szekanecz Z
Autoimmun Rev; 2012 Oct; 11(12):852-5. PubMed ID: 22410174
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.
Kuo CF; See LC; Yu KH; Chou IJ; Tseng WY; Chang HC; Shen YM; Luo SF
Scand J Rheumatol; 2011; 40(5):373-8. PubMed ID: 21388247
[TBL] [Abstract][Full Text] [Related]
37. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort.
Marangoni RG; Rocha LF; Del Rio AP; Yoshinari NH; Marques-Neto JF; Sampaio-Barros PD
Rheumatology (Oxford); 2013 Aug; 52(8):1520-4. PubMed ID: 23661427
[TBL] [Abstract][Full Text] [Related]
38. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.
Yuen SY; Rochwerg B; Ouimet J; Pope JE
J Rheumatol; 2008 Jun; 35(6):1073-8. PubMed ID: 18412305
[TBL] [Abstract][Full Text] [Related]
39. Time to diagnosis in systemic sclerosis: is sex a factor?
Hudson M; Thombs B; Baron M;
Arthritis Rheum; 2009 Feb; 61(2):274-8. PubMed ID: 19177534
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
Sato S; Komura K; Hasegawa M; Fujimoto M; Takehara K
J Rheumatol; 2001 Nov; 28(11):2460-5. PubMed ID: 11708419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]